Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 38: 2093-2095, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, B. D.

Clinical Chemistry, Vol 38, 2093-2095, Copyright © 1992 by American Association for Clinical Chemistry

Laboratory evaluation of the Glucocard blood glucose test meter

BD Lewis
Department of Clinical Biochemistry, Green Lane/National Women's Hospital, Auckland, New Zealand.

The Glucocard (Kyoto Daiichi Kagaku) blood glucose meter is designed for self-monitoring of blood glucose concentrations in capillary blood through use of an electrochemical test strip. Evaluated in this laboratory, the Glucocard had CVs of 4.6%, 6.6%, and 3.5% at blood glucose concentrations of 2.4, 4.1, and 18.9 mmol/L, respectively. The meter's response varied linearly with blood glucose concentration between 2.2 and 27.8 mmol/L. Hemolysis, urate, ascorbate, and acetaminophen interfered by > 5%. Different hematocrits, in the range 0.20-0.70, did not affect the measured glucose concentration. Comparison with glucose results measured in whole blood with a NOVA Stat Profile 5 instrument yielded the following: Glucocard = 0.898 NOVA- -0.184 (r = 0.995). The main advantages of the Glucocard are its small sample volume (5 microL), wide linear range, and fully automated sample- handling steps, which reduce user-related variability.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
B. Meric, N. Kilicaslan, K. Kerman, D. Ozkan, U. Kurun, N. Aksu, and M. Ozsoz
Performance of Precision G Blood Glucose Analyzer with a New Test Strip G2b on Neonatal Samples
Clin. Chem., January 1, 2002; 48(1): 179 - 180.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
L.-J. Cartier, P. Leclerc, M. Pouliot, L. Nadeau, G. Turcotte, and B. Fruteau-de-Laclos
Toxic Levels of Acetaminophen Produce a Major Positive Interference on Glucometer Elite and Accu-chek Advantage Glucose Meters
Clin. Chem., April 1, 1998; 44(4): 893 - 894.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.